● LIVE
Updated 1d ago
· 14 sources tracked
Lilly, J&J and AbbVie Hit New Highs
Eli Lilly, Johnson & Johnson, AbbVie, and Biogen reached new 52-week highs on June 26. The gains occurred as the healthcare sector outperformed the broader market. A biotech rally and company-specific catalysts drove the momentum.
What changed
Four major healthcare companies hit 52-week highs during a sector-wide rally on June 26.
Live updates
-
Major Healthcare Stocks Reach New 52-Week Highs
confidence 90%Eli Lilly, Johnson & Johnson, AbbVie, and Biogen reached new 52-week highs on June 26. The gains occurred as the healthcare sector outperformed the broader market. A biotech rally and company-specific catalysts drove the momentum.
What's confirmed:
- Eli Lilly, Johnson & Johnson, and AbbVie hit new 52-week highs.
- Biogen also reached a new 52-week high on June 26.
- The healthcare sector outperformed the broader market.
Still unconfirmed:
- The biotech sector rallied 9%.
- Healthcare stocks became a haven for investors leaving tech.